Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 10-Q

(Mark One)

     
x   Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the quarterly period ended September 30, 2003 or
     
o   Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    For the transition period from                  to      

Commission File Number 0-23639

PROVINCE HEALTHCARE COMPANY

(Exact Name of Registrant as Specified in Its Charter)
     
Delaware
(State or Other Jurisdiction of
Incorporation or Organization)
  62-1710772
(I.R.S. Employer
Identification No.)
     
105 Westwood Place
Suite 400
Brentwood, Tennessee

(Address of Principal Executive Offices)
  37027
(Zip Code)

(615) 370-1377
(Registrant’s Telephone Number, Including Area Code)

     Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes x   No o

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act)
Yes x   No o

     Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

     
Class
Common Stock, $.01 par value
  Outstanding at November 1, 2003
48,729,834 shares

 


TABLE OF CONTENTS

PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
ITEM 4. CONTROLS AND PROCEDURES
PART II OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EX-31.1 SECTION 302 CEO CERTIFICATION
EX-31.2 SECTION 302 CFO CERTIFICATION
EX-32.1 SECTION 906 CERTIFICATION


Table of Contents

           
PART I
FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
       
 
Condensed Consolidated Balance Sheets
September 30, 2003 and December 31, 2002
    1  
 
Condensed Consolidated Statements of Income
Three Months Ended September 30, 2003 and 2002
    2  
 
Condensed Consolidated Statements of Income
Nine Months Ended September 30, 2003 and 2002
    3  
 
Condensed Consolidated Statements of Cash Flows
Nine Months Ended September 30, 2003 and 2002
    4  
 
Notes to Condensed Consolidated Financial Statements
    5  
Item 2. Management’s Discussion and Analysis of Financial Condition And Results of Operations
    12  
Item 3. Quantitative and Qualitative Disclosures About Market Risk
    23  
Item 4. Controls and Procedures
    23  
PART II
OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K
    24  
Signatures
    26  

 


Table of Contents

ITEM 1. FINANCIAL STATEMENTS

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)
                     
        September 30,   December 31,
        2003   2002
       
 
        (Unaudited)   (Note 1)
ASSETS
               
Current assets:
               
 
Cash and cash equivalents
  $ 38,804     $ 14,417  
 
Accounts receivable, less allowance for doubtful accounts of $62,173 in 2003 and $68,158 in 2002
    114,378       117,431  
 
Inventories
    19,131       19,835  
 
Prepaid expenses and other
    15,710       14,071  
 
   
     
 
 
    188,023       165,754  
Property and equipment, net
    463,949       447,379  
Goodwill
    318,014       319,390  
Unallocated purchase price
    3,247       466  
Other assets
    40,435       38,722  
 
   
     
 
 
  $ 1,013,668     $ 971,711  
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
 
Accounts payable
  $ 17,680     $ 20,162  
 
Accrued salaries and benefits
    25,903       25,380  
 
Accrued expenses
    25,701       13,198  
 
Current portion of long-term debt
    1,724       1,668  
 
   
     
 
 
    71,008       60,408  
Long-term debt, less current portion
    451,546       461,576  
Other liabilities
    44,577       33,913  
Minority interests
    2,726       2,612  
 
Commitments and Contingencies
           
 
Stockholders’ equity:
               
 
Preferred stock — $0.01 par value, 100,000 shares authorized, none issued and outstanding
           
 
Common stock — $0.01 par value; 150,000,000 shares authorized at September 30, 2003 and December 31, 2002, issued and outstanding 48,734,607 shares and 48,581,549 shares at September 30, 2003 and December 31, 2002, respectively
    487       486  
 
Additional paid-in-capital
    305,457       304,102  
 
Retained earnings
    138,886       109,567  
 
Accumulated other comprehensive loss
    (1,019 )     (953 )
 
   
     
 
   
Total stockholders’ equity
    443,811       413,202  
 
   
     
 
 
  $ 1,013,668     $ 971,711  
 
   
     
 

See accompanying notes

1


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(In thousands, except per share data)
                     
        Three Months Ended September 30,
       
        2003   2002
       
 
Revenue:
               
 
Net patient service revenue
  $ 189,091     $ 178,111  
 
Other
    6,338       5,851  
 
   
     
 
   
Net operating revenue
    195,429       183,962  
 
Expenses:
               
 
Salaries, wages and benefits
    71,109       72,115  
 
Purchased services
    18,038       19,305  
 
Supplies
    24,738       23,396  
 
Provision for doubtful accounts
    20,008       14,042  
 
Other operating expenses
    25,827       21,576  
 
Rentals and leases
    2,385       2,165  
 
Depreciation and amortization
    9,738       9,419  
 
Interest expense
    7,097       6,218  
 
Minority interests
    52       16  
 
Loss on sale of assets
    82        
 
Loss on early extinguishment of debt
    10        
 
   
     
 
   
Total expenses
    179,084       168,252  
 
   
     
 
Income before provision for income taxes
    16,345       15,710  
Income taxes
    6,538       6,284  
 
   
     
 
Net income
  $ 9,807     $ 9,426  
 
   
     
 
Net income per common share (Note 7):
               
 
Basic
  $ 0.20     $ 0.19  
 
   
     
 
 
Diluted
  $ 0.20     $ 0.19  
 
   
     
 

See accompanying notes

2


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(In thousands, except per share data)
                     
        Nine Months Ended September 30,
       
        2003   2002
       
 
Revenue:
               
 
Net patient service revenue
  $ 566,298     $ 506,125  
 
Other
    19,344       17,438  
 
   
     
 
   
Net operating revenue
    585,642       523,563  
 
Expenses:
               
 
Salaries, wages and benefits
    221,379       201,743  
 
Purchased services
    54,699       54,605  
 
Supplies
    73,344       63,606  
 
Provision for doubtful accounts
    54,991       41,533  
 
Other operating expenses
    76,120       60,275  
 
Rentals and leases
    7,241       6,518  
 
Depreciation and amortization
    28,515       25,751  
 
Interest expense
    19,716       15,959  
 
Minority interests
    201       72  
 
Loss on sale of assets
    85       53  
 
Loss on early extinguishment of debt
    486        
 
   
     
 
   
Total expenses
    536,777       470,115  
 
   
     
 
Income before provision for income taxes
    48,865       53,448  
Income taxes
    19,546       21,379  
 
   
     
 
Net income
  $ 29,319     $ 32,069  
 
   
     
 
Net income per common share (Note 7):
               
 
Basic
  $ 0.60     $ 0.67  
 
   
     
 
 
Diluted
  $ 0.60     $ 0.64  
 
   
     
 

See accompanying notes

3


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In thousands)
                       
          Nine Months Ended September 30,
         
          2003   2002
         
 
Cash flows from operating activities:
               
 
Net income
  $ 29,319     $ 32,069  
 
Adjustments to reconcile net income to net cash provided by operating activities:
               
   
Depreciation and amortization
    28,515       25,751  
   
Deferred income taxes
    3,469       1,840  
   
Provision for professional liability
    4,806       5,403  
   
Loss on early extinguishment of debt
    486        
   
Loss on sale of assets
    85       53  
   
Changes in operating assets and liabilities, net of effects from acquisitions and disposals:
               
     
Accounts receivable
    4,068       (2,480 )
     
Inventories
    637       (1,311 )
     
Prepaid expenses and other
    1,968       4,322  
     
Accounts payable and accrued expenses
    10,021       8,488  
     
Accrued salaries and benefits
    523       (1,873 )
   
Other
    6,173       2,973  
 
   
     
 
 
Net cash provided by operating activities
    90,070       75,235  
Cash flows from investing activities:
               
 
Purchase of property and equipment
    (44,406 )     (36,109 )
 
Purchase of hospitals and healthcare entities
    (3,247 )     (171,707 )
 
   
     
 
 
Net cash used in investing activities
    (47,653 )     (207,816 )
Cash flows from financing activities:
               
 
Proceeds from long-term debt
    194,199       134,355  
 
Repayments of debts
    (213,585 )     (39,451 )
 
Issuance of common stock
    1,356       10,505  
 
   
     
 
 
Net cash (used in) provided by financing activities
    (18,030 )     105,409  
 
   
     
 
Increase (decrease) in cash and cash equivalents
    24,387       (27,172 )
Cash and cash equivalents at beginning of period
    14,417       39,375  
 
   
     
 
Cash and cash equivalents at end of period
  $ 38,804     $ 12,203  
 
   
     
 
Interest payments
  $ 10,603     $ 10,323  
Income taxes (refund) received, net
  $ (7,013 )   $ (6,998 )

See accompanying notes

4


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. BASIS OF PRESENTATION

     The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. Interim results are not necessarily indicative of results that may be expected for the full year. In the opinion of management, the accompanying interim financial statements contain all material adjustments, consisting only of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of Province Healthcare Company (the “Company”).

     The balance sheet at December 31, 2002, has been derived from the audited consolidated financial statements at that date, but does not include all of the financial information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

     For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2002.

2. USE OF ESTIMATES

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management of the Company to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Actual results could differ from the estimates.

5


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

3. ACQUISITIONS

     Memorial Hospital of Martinsville and Henry County

     In May 2002, the Company acquired Memorial Hospital of Martinsville and Henry County in Martinsville, Virginia, for approximately $129.2 million, including working capital. To finance this acquisition, the Company borrowed $86.0 million under its revolving credit facility and used approximately $43.2 million of available cash. This is the Company’s first Virginia hospital and is the only hospital in the county, serving a population in excess of 100,000.

     Los Alamos Medical Center

     In June 2002, the Company acquired Los Alamos Medical Center in Los Alamos, New Mexico, for approximately $39.0 million, including working capital. To finance this acquisition, the Company borrowed $37.0 million under its revolving credit facility and used $2.0 million from available cash. This is the Company’s first New Mexico hospital and is the only hospital in the community, serving a population of approximately 50,000.

     Other

     In May 2003, the Company acquired a radiology and laboratory business in Elko, Nevada, where the Company operates Northeastern Nevada Regional Hospital, for approximately $3.2 million. The purchase price is not yet allocated, pending the Company’s receipt of a final appraisal of the healthcare business.

     The operating results of the hospitals and healthcare business acquired in 2002 and 2003 have been included in the accompanying condensed consolidated statements of income from the respective dates of acquisition.

4. GOODWILL AND INTANGIBLE ASSETS

     The Company adopted Statement of Financial Accounting Standards No. 142 (“SFAS No. 142”), Goodwill and Other Intangible Assets, effective January 1, 2002. Under SFAS No. 142, goodwill is no longer amortized, but is subject to annual impairment tests, or more frequently if certain indicators arise. The Company performed its annual impairment test on October 1, 2002. The results of the tests had no effect on the operations or financial position of the Company. The Company currently is not aware of any impairment indicators at September 30, 2003.

6


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

     The Company has other intangible assets, net of accumulated amortization, of $1.2 million as of September 30, 2003, which are included in “other assets” on the condensed consolidated balance sheet. The intangible assets relate primarily to non-compete agreements and are amortized over two (2) years.

5. LONG-TERM DEBT

     In May 2003, the Company completed its public offering of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due 2013 at par. Net proceeds of the offering totaling $194.2 million were used to repay $114.3 million in existing borrowings under our senior credit facility and to repurchase approximately $69.0 million of the Company’s 4 1/2% Convertible Subordinated Notes due 2005 through privately negotiated transactions. The Company recorded a $486,000 pretax loss associated with the early extinguishment of debt related to this repurchase. During May and June 2003, the Company amended its senior credit facility to (i) add additional hospitals as collateral security, (ii) obtain consent for various transactions, including the issuance of $200.0 million of Senior Subordinated Notes due 2013 and repurchase of a portion of the outstanding 4 1/2% Convertible Subordinated Notes due 2005, (iii) increase the flexibility of certain investment covenants, and (iv) increase the amount available on its revolving line of credit to $250.0 million from $209.7 million.

     In July, the Company repurchased an additional $5.0 million of the outstanding 4 1/2% Convertible Subordinated Notes due 2005, bringing total repurchases to $74.0 million and reducing the outstanding principal balance of such Notes to $76.0 million. An insignificant loss was recorded in the third quarter of 2003 related to this repurchase.

     During the second quarter of 2003, the Company terminated its previously existing interest rate swap contract at fair value, which was recorded as a liability on the balance sheet. The loss on the termination was not considered material. During the third quarter of 2003, the Company entered into an interest rate swap agreement which effectively converted, for a ten-year period, $100.0 million of the $200.0 million fixed-rate borrowings under its 7 1/2% Senior Subordinated Notes due 2013 to floating rate borrowings. This agreement exposes the Company to credit losses in the event of non-performance by the counterparty to the financial instrument. The Company anticipates that the counterparty will fully satisfy its obligations under the contract.

     The Company entered into an interest rate swap agreement in July 2003, which effectively converted for a ten-year period $100.0 million of the $200.0 million fixed-rate borrowings under the 7 1/2% Senior Subordinated Notes due 2013 to floating-rate borrowings. The Company secured a LIBOR plus 2.79% floating interest rate over the term of the interest

7


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

rate swap agreement. In accordance with the provisions of SFAS No. 133, the Company designated its interest rate swap agreement as a fair value hedge.

6. COMPREHENSIVE INCOME

     The following table presents the components of comprehensive income, net of related taxes (in thousands):

                                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
   
 
    2003   2002   2003   2002
   
 
 
 
Net income
  $ 9,807     $ 9,426     $ 29,319     $ 32,069  
Net change in fair value of interest rate swap
    130       (177 )     (65 )     4  
 
   
     
     
     
 
Comprehensive income
  $ 9,937     $ 9,249     $ 29,254     $ 32,073  
 
   
     
     
     
 

The net change in fair value of the interest rate swap is included in retained earnings on the condensed consolidated balance sheets.

7. EARNINGS PER SHARE

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

                                     
        Three Months Ended   Nine Months Ended
        September 30,   September 30,
       
 
        2003   2002   2003   2002
       
 
 
 
Numerator:
                               
 
Net income
  $ 9,807     $ 9,426     $ 29,319     $ 32,069  
 
Add convertible notes interest net of tax
                      7,302  
 
   
     
     
     
 
 
Adjusted net income
  $ 9,807     $ 9,426     $ 29,319     $ 39,371  
 
   
     
     
     
 
Denominator:
                               
 
Denominator for basic income per share — Weighted-average shares
    48,729       48,544       48,681       48,002  
 
Effective of dilutive securities — Employee stock options
    910       1,063       462       1,523  
 
Convertible notes
                      11,899  
 
   
     
     
     
 
 
Denominator for diluted income per share — Adjusted weighted-average shares
    49,639       49,607       49,143       61,424  
 
   
     
     
     
 
Basic net income per share
  $ 0.20     $ 0.19     $ 0.60     $ 0.67  
 
   
     
     
     
 
Diluted net income per share
  $ 0.20     $ 0.19     $ 0.60     $ 0.64  
 
   
     
     
     
 

8


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

     The add-back of the interest and potential issuance of shares related to the convertible notes was not included in the computation for the three and nine months ended September 30, 2003, and the three months ended September 30, 2002, because the effect would have been anti-dilutive.

8. STOCK BASED COMPENSATION

     The Company, from time to time, grants stock options for a fixed number of common shares to employees and directors. The Company accounts for employee stock option grants using the intrinsic value method in accordance with Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (“Opinion 25”), and related interpretations, and accordingly, recognizes no compensation expense for the stock option grants when the exercise price of the options equals, or is greater than, the market price of the underlying stock on the date of grant.

     The following pro forma information is being presented in accordance with SFAS No. 148, Accounting for Stock-Based Compensation-Transition & Disclosure (adopted by the Company on January 1, 2003). If the compensation cost for the Company’s stock-based compensation plans had been determined based on the fair value at the grant date for awards under these plans consistent with the methodology prescribed under SFAS No. 123, Accounting for Stock-Based Compensation, net income and earnings per share would have been reduced to the pro forma amounts indicated in the following table:

                                   
      Three Months Ended   Nine Months Ended
      September 30,   September 30,
     
 
      2003   2002   2003   2002
     
 
 
 
Net income – as reported
  $ 9,807     $ 9,426     $ 29,319     $ 32,069  
Less stock-based compensation expense determined under a fair value method, net of income taxes
    (1,161 )     (1,096 )     (3,328 )     (10,183 )
 
   
     
     
     
 
Pro forma net income
  $ 8,646     $ 8,330     $ 25,991     $ 21,886  
 
   
     
     
     
 
Basic earnings per share
                               
 
As reported
  $ 0.20     $ 0.19     $ 0.60     $ 0.67  
 
Pro forma
  $ 0.18     $ 0.17     $ 0.53     $ 0.46  
Diluted earnings per share
                               
 
As reported
  $ 0.20     $ 0.19     $ 0.60     $ 0.64  
 
Pro forma
  $ 0.17     $ 0.17     $ 0.53     $ 0.44  

9


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

     The weighted average fair values of the Company’s stock options granted during the three months ended September 30, 2003 and 2002 and nine months ended September 30, 2003 and 2002 were $5.76, $9.85, $3.94 and $9.79, respectively. The fair values were estimated at the date of grant using a Black-Scholes option valuation model based on the following weighted-average assumptions:

                                 
    Three Months Ended   Nine Months Ended
    September 30,   September 30,
   
 
    2003   2002   2003   2002
   
 
 
 
Risk-free interest rate
    3.0 %     3.3 %     2.4 %     4.2 %
Dividend yield
    0.0 %     0.0 %     0.0 %     0.0 %
Volatility
    59.4 %     59.4 %     63.6 %     59.4 %
Expected life (in years)
    4.0       5.0       4.0       3.8  

     The Black-Scholes option valuation model was developed for use in estimating the fair value of traded options that have no vesting restrictions and are fully transferable. Option valuation models require the input of highly subjective assumptions including the expected stock price volatility. The Company’s employee stock options have characteristics significantly different from those of traded options. Changes in subjective input assumptions can materially affect the fair value estimate. Other option valuation models may produce significantly different fair values of the Company’s employee stock options.

9. COMMITMENTS AND CONTINGENCIES

     Management continually evaluates contingencies based on the best available evidence and believes that adequate provision for losses has been provided to the extent necessary. In the opinion of management, the ultimate resolution of the following contingencies will not have a material effect on the Company’s results of operations or financial position.

     Commitments

     Subsequent to quarter end, the Company began construction of a new 41-bed hospital facility in Bluffton, South Carolina, which is expected to be completed in the first quarter of 2005. The total cost of this facility is expected to approximate $32.0 million, with the majority funded during 2004.

     General and Professional Liability Risks

     Effective January 1, 2003, the Company increased its self-insurance retention related to general and professional liability risks to $5.0 million. The 2003 policy provides coverage up to $50.0 million for claims incurred during the annual policy term.

     The Company estimates its self-insured retention portion of the malpractice risks using historical claims data, demographic factors, severity factors and other actuarial assumptions. The Company maintains a reserve for the anticipated claims within its deductible and self-insured retentions. The reserve for general and professional liability risks is included in “other liabilities” on the condensed consolidated balance sheet.

10


Table of Contents

PROVINCE HEALTHCARE COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited) – (continued)

     Workers Compensation Risks

     Effective January 1, 2003, the Company increased its deductible for workers compensation claims to $500,000 per accident. The Company has purchased a minimum cap of $12.0 million for total workers compensation losses within this deductible for 2003. The Company’s arrangement with the insurance provider allows us to prepay the expected amounts of annual workers compensation claims, which is based upon claims experience. The claims processor tracks payments for the policy year. At the end of the policy year, the claims processor compares the total amount prepaid by us to the actual amount paid by the claims processor. This comparison will ultimately result in a receivable from or a payable to the claims processor.

     Litigation

     The Company currently is, and from time to time is expected to be, subject to claims and suits arising in the ordinary course of business. The Company is not aware of any such proceeding which, in management’s opinion, would have a material adverse effect on the Company’s business, financial condition or results of operations.

     Net Patient Service Revenue

     Final determination of amounts earned under the Medicare and Medicaid programs often occurs in subsequent periods because of audits by the programs, rights of appeal and the application of numerous technical provisions. Differences between original estimates and subsequent revisions (including settlements) are included in the consolidated statements of income in the period in which revisions are made, and resulted in an increase in net patient service revenue of approximately $2.8 million and $1.2 million the three month periods ended September 30, 2003 and 2002, respectively; and $3.6 million and $1.3 million for the nine month periods ended September 30, 2003 and 2002, respectively.

10. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

     In January 2003, the Financial Accounting Standards Board issued Interpretation No. 46, Consolidation of Variable Interest Entities, an Interpretation of Accounting Research Bulletin No. 51 (“FIN 46”). FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46, as amended, must be applied for the first interim or annual period after December 15, 2003. The Company does not expect this new interpretation to have a material effect on its future results of operations or financial position.

11


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

     You should read the following along with the Condensed Consolidated Financial Statements and accompanying notes.

OVERVIEW

     We are a healthcare services company focused on acquiring and operating hospitals in attractive non-urban markets in the United States. As of September 30, 2003, we owned or leased 20 general acute care hospitals in 13 states with a total of 2,281 licensed beds, and managed 37 hospitals in 14 states, with a total of 3,043 licensed beds.

     Our owned and leased hospitals accounted for 98.0% and 98.1% of our net operating revenue in the three months ended September 30, 2003 and 2002, respectively.

IMPACT OF ACQUISITIONS

     An integral part of our strategy is to acquire non-urban acute care hospitals. Because of the relatively small number of owned and leased hospitals, each hospital acquisition can materially affect our overall operating performance. Upon the acquisition of a hospital, we typically take a number of steps to lower operating costs. The impact of such actions may be offset by cost increases to expand services, strengthen medical staff and improve market position. The benefits of these investments and of other activities to improve operating margins generally do not occur immediately. Consequently, the financial performance of a newly-acquired hospital may adversely affect overall operating margins in the near term. As we make additional hospital acquisitions, we expect that this effect will be mitigated by the expanded financial base of existing hospitals and the allocation of corporate overhead among a larger number of hospitals. We also may divest certain hospitals in the future, if we determine a hospital no longer fits within our strategy.

12


Table of Contents

RESULTS OF OPERATIONS

Operating Results Summary

     The following are comparative summaries of results from operations for the three months and nine months ended September 30, 2003 and 2002 (dollars in thousands):

                                               
          Three Months Ended September 30,        
         
       
          2003   2002        
         
 
       
                  % of           % of   % Change
          Amount   Revenues   Amount   Revenues   from prior year
         
 
 
 
 
Revenue:
                                       
 
Net patient service revenue
  $ 189,091             $ 178,111                  
 
Other
    6,338               5,851                  
 
   
             
                 
     
Net operating revenue
    195,429       100.0 %     183,962       100.0 %     6.2 %
Expenses:
                                       
 
Salaries, wages and benefits
    71,109       36.4       72,115       39.2          
 
Purchases services
    18,038       9.2       19,305       10.5          
 
Supplies
    24,738       12.7       23,396       12.7          
 
Provision for doubtful accounts
    20,008       10.2       14,042       7.6          
 
Other operating expenses
    25,827       13.2       21,576       11.8          
 
Rentals and leases
    2,385       1.2       2,165       1.2          
 
Depreciation and amortization
    9,738       5.1       9,419       5.1          
 
Interest expense
    7,097       3.6       6,218       3.4          
 
Minority interests
    52             16                
 
Loss on sale of assets
    82                            
 
Loss on early extinguishment
    10                            
 
   
     
     
     
         
Income before provision for income taxes
    16,345       8.4       15,710       8.5       4.0 %
Income taxes
    6,538       3.4       6,284       3.4          
 
   
     
     
     
         
Net income
  $ 9,807       5.0 %   $ 9,426       5.1 %     4.0 %
 
   
     
     
     
         
Net income per common share:
                                       
   
Basic
  $ 0.20             $ 0.19                  
 
   
             
                 
   
Diluted
  $ 0.20             $ 0.19                  
 
   
             
                 

13


Table of Contents

                                               
          Nine Months Ended September 30,        
         
       
          2003   2002        
         
 
       
                  % of           % of   % Change
          Amount   Revenues   Amount   Revenues   from prior year
         
 
 
 
 
Revenue:
                                       
 
Net patient service revenue
  $ 566,298             $ 506,125                  
 
Other
    19,344               17,438                  
 
   
             
                 
     
Net operating revenue
    585,642       100.0 %     523,563       100.0 %     11.9 %
Expenses:
                                       
 
Salaries, wages and benefits
    221,379       37.8       201,743       38.5          
 
Purchases services
    54,699       9.3       54,605       10.4          
 
Supplies
    73,344       12.5       63,606       12.1          
 
Provision for doubtful accounts
    54,991       9.4       41,533       7.9          
 
Other operating expenses
    76,120       13.1       60,275       11.7          
 
Rentals and leases
    7,241       1.2       6,518       1.2          
 
Depreciation and amortization
    28,515       4.9       25,751       4.9          
 
Interest expense
    19,716       3.5       15,959       3.1          
 
Minority interests
    201             72                
 
Loss on sale of assets
    85             53                
 
Loss on early extinguishment of debt
    486                            
 
   
     
     
     
         
Income before provision for income taxes
    48,865       8.3       53,448       10.2       (8.6 %)
Income taxes
    19,546       3.3       21,379       4.1          
 
   
     
     
     
         
Net income
  $ 29,319       5.0 %   $ 32,069       6.1 %     (8.6 %)
 
   
     
     
     
         
Net income per common share:
                                       
   
Basic
  $ 0.60             $ 0.67                  
 
   
             
                 
   
Diluted
  $ 0.60             $ 0.64                  
 
   
             
                 

14


Table of Contents

                             
        Three Months Ended September 30,
       
        2003   2002   % Change
       
 
 
Consolidated Hospitals:
                       
 
Number of hospitals at end of period
    20       20       %
 
Licensed beds at end of period (a)
    2,281       2,315       (1.5 )
 
Beds in service at end of period
    1,993       1,905       4.6  
 
Net patient service revenue (in thousands)
  $ 189,091     $ 178,111       6.2  
 
Admissions (b)
    18,683       18,584       0.5  
 
Adjusted admissions (c)
    34,284       33,520       2.3  
 
Patient days (d)
    76,084       77,738       (2.1 )
 
Adjusted patient days (e)
    139,634       140,250       (0.4 )
 
Average length of stay (days) (f)
    4.1       4.2       (2.4 )
 
Gross revenue (in thousands) (g):
                       
   
Inpatient
  $ 228,966     $ 213,510       7.2  
   
Outpatient
    191,130       171,600       11.4  
 
   
     
     
 
 
  $ 420,096     $ 385,110       9.1 %
 
   
     
     
 
Same Hospitals (h):
                       
 
Number of hospitals at end of period
    20       20       %
 
Licensed beds at end of period (a)
    2,281       2,315       (1.5 )
 
Beds in service at end of period
    1,993       1,905       4.6  
 
Net patient service revenue (in thousands)
  $ 189,091     $ 178,111       6.2  
 
Admissions (b)
    18,683       18,584       0.5  
 
Adjusted admissions (c)
    34,284       33,520       2.3  
 
Patient days (d)
    76,084       77,738       (2.1 )
 
Adjusted patient days (e)
    139,634       140,250       (0.4 )
 
Average length of stay (days) (f)
    4.1       4.2       (2.4 )
 
Gross revenue (in thousands) (g):
                       
   
Inpatient
  $ 228,966     $ 213,510       7.2  
   
Outpatient
    191,130       171,600       11.4  
 
   
     
     
 
 
  $ 420,096     $ 385,110       9.1 %
 
   
     
     
 

See footnotes following next table

15


Table of Contents

                             
        Nine Months Ended September 30,
       
        2003   2002   % Change
       
 
 
Consolidated Hospitals:
                       
 
Number of hospitals at end of period
    20       20       %
 
Licensed beds at end of period (a)
    2,281       2,315       (1.5 )
 
Beds in service at end of period
    1,993       1,905       4.6  
 
Net patient service revenue (in thousands)
  $ 566,298     $ 506,125       11.9  
 
Admissions (b)
    56,971       54,432       4.7  
 
Adjusted admissions (c)
    102,477       93,773       9.3  
 
Patient days (d)
    238,340       234,492       1.6  
 
Adjusted patient days (e)
    428,648       403,590       6.2  
 
Average length of stay (days) (f)
    4.2       4.3       (2.3 )
 
Gross revenue (in thousands) (g):
                       
   
Inpatient
  $ 705,158     $ 633,588       11.3  
   
Outpatient
    563,273       457,010       23.3  
 
   
     
     
 
 
  $ 1,268,431     $ 1,090,598       16.3 %
 
   
     
     
 
Same Hospitals (h):
                       
 
Number of hospitals at end of period
    20       20       %
 
Licensed beds at end of period (a)
    2,281       2,315       (1.5 )
 
Beds in service at end of period
    1,993       1,905       4.6  
 
Net patient service revenue (in thousands)
  $ 502,347     $ 488,904       2.7  
 
Admissions (b)
    52,546       53,019       (0.9 )
 
Adjusted admissions (c)
    92,655       90,833       2.0  
 
Patient days (d)
    219,025       228,602       (4.2 )
 
Adjusted patient days (e)
    386,040       391,263       (1.3 )
 
Average length of stay (days) (f)
    4.2       4.3       (2.3 )
 
Gross revenue (in thousands) (g):
                       
   
Inpatient
  $ 658,757     $ 621,281       6.0  
   
Outpatient
    502,448       442,363       13.6  
 
   
     
     
 
 
  $ 1,161,205     $ 1,063,644       9.2 %
 
   
     
     
 

  (a)   Beds for which a hospital has been granted approval to operate from the applicable state licensing agency.
 
  (b)   Represents the total number of patients admitted (in a facility for a period in excess of 23 hours) and used by management and investors as a general measure of inpatient volume.
 
  (c)   Used by management and investors as a general measure of combined inpatient and outpatient volume. Adjusted admissions are computed by multiplying admissions (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted admissions computation equates outpatient revenue to the volume measure (admissions) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
 
  (d)   Represents the total number of days the patients who are admitted stay in our hospitals.
 
  (e)   Used by management and investors as a general measure of combined inpatient and outpatient volume. Adjusted patient days are computed by multiplying patient days (inpatient volume) by the outpatient factor. The outpatient factor is the sum of gross inpatient revenue and gross outpatient revenue divided by gross inpatient revenue. The adjusted patient days computation equates outpatient revenue to the volume measure (patient days) used to measure inpatient volume, resulting in a general measure of combined inpatient and outpatient volume.
 
  (f)   The average number of days admitted patients stay in our hospitals.
 
  (g)   Represents revenues prior to reductions for discounts and contractual allowances.
 
  (h)   Same hospital information includes the operations of only those hospitals which were owned or leased during both entire periods presented. Consolidated and same hospital amounts are equal for the three-month periods ended September 30, 2003 and 2002, because there was no change in the number of hospitals owned or leased since the beginning of the three months ended September 30, 2002.

16


Table of Contents

Three Months Ended September 30, 2003 Compared to Three Months Ended September 30, 2002

     Net operating revenue increased 6.2% or $11.4 million to $195.4 million for the three months ended September 30, 2003, compared to the same period last year. The increase was primarily attributable to a 3.8% increase in same hospital net revenue per adjusted admissions and a 2.3% increase in adjusted admissions. Net operating revenue also includes adjustments to estimated third party payor settlements.

     Salaries, wages and benefits as a percentage of net operating revenue, decreased to 36.4% from 39.2%, primarily due to continued implementation of our flexible staffing standards, which effectively matches labor with hospital volume trends, and to containment of our employee benefit expenses.

     Purchased services, as a percentage of net operating revenue, decreased to 9.2% for the three months ended September 30, 2003, compared to 10.5% for the comparable period of the prior year. This decrease is primarily attributable to reductions in contract labor and collection fees as our company was less reliant on outside collection consultants and staffing.

     Supplies remained at 12.7% of net operating revenue for the three months ended September 30, 2003, compared to the same period of 2002.

     The provision for doubtful accounts increased to 10.2% of net operating revenue for the three months ended September 30, 2003 compared to 7.6% for the comparable period of 2002, primarily due to increases in self-pay and uninsured patient volumes as a percentage of total patient volumes, and the corresponding effect of rate increases on those accounts. The net revenues associated with those patients are generally recorded at gross charges, which are typically higher than what government programs and managed care plans pay. As a result, failure to receive payments from self-pay and uninsured patients results in higher provision for doubtful accounts as a percentage of net operating revenue. The provision for doubtful accounts is expected to remain in the range of 10% of net operating revenue through the first half of 2004.

     Other operating expenses increased as a percentage of net operating revenue to 13.2% from 11.8% in the prior year primarily due to increases in insurance costs and physician recruitment expenses.

     Rentals and leases were unchanged as a percentage of net operating revenue for both periods.

     Depreciation and amortization expense increased $0.3 million to $9.7 million for the three months ended September 30, 2003 compared to the same period last year and remained at 5.1% of net operating revenue.

     Interest expense increased to $7.1 million for the three months ended September 30, 2003, compared to $6.2 million for the comparable period of 2002. The increase was primarily due to the May 27, 2003, issuance of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due 2013, offset by repayments of outstanding borrowings on our senior bank

17


Table of Contents

credit facility, repurchases of a portion of our outstanding 4 1/2% Convertible Subordinated Notes due 2005 and entering into a $100.0 million fixed to floating interest rate swap agreement during the three months ended September 30, 2003.

     The provision for income taxes was $6.5 million for the three months ended September 30, 2003, compared to $6.3 million for the comparable period of 2002, primarily due to the increase in pre-tax income.

Nine Months Ended September 30, 2003 Compared to Nine Months Ended September 30, 2002

     Net operating revenue increased 11.9% or $62.0 million to $585.6 million for the nine months ended September 30, 2003, compared to the same period last year. The increase was primarily attributable to the acquisitions of Los Alamos Medical Center and Memorial Hospital of Martinsville and Henry County, which were completed in the second quarter of last year. Net operating revenue also includes adjustments to estimated third party payor settlements.

     Salaries, wages and benefits as a percentage of net operating revenue, decreased to 37.8% from 38.5% for the nine months ended September 30, 2003 compared to the same period last year, primarily due to improvements resulting from implementation of our flexible staffing standards throughout our hospitals, which effectively matches labor with hospital volume trends, and to containment of our employee benefit expenses.

     Purchased services, as a percentage of net operating revenue, decreased to 9.3% for the nine months ended September 30, 2003, compared to 10.4% for the comparable period of the prior year. This decrease is primarily attributable to reductions in contract labor and collection fees as our Company was less reliant on outside collection consultants and staffing.

     Supplies increased to 12.5% of net operating revenue, for the nine months ended September 30, 2003, compared to 12.1% for the comparable period of 2002, due primarily to the acquisitions of Memorial Hospital of Martinsville and Henry County and Los Alamos Medical Center.

     The provision for doubtful accounts increased to 9.4% of net operating revenue for the nine months ended September 30, 2003 compared to 7.9% for the comparable period of 2002, primarily due to the increases in self-pay and uninsured patient volumes as a percent of total patient volumes and the corresponding effect of rate increases on those accounts. The net patient service revenues associated with those patients are generally recorded at gross charges, which are typically higher than what government programs and managed care plans pay. As a result, failure to receive payments from self-pay and uninsured patients results in a higher provision for doubtful accounts as a percentage of net operating revenue.

     Other operating expenses increased as a percentage of net operating revenue to 13.1% from 11.7% in the prior year primarily due to increases in insurance costs and physician recruitment expenses.

18


Table of Contents

     Rentals and leases were relatively unchanged as a percentage of net operating revenue for both periods.

     Depreciation and amortization expense increased $2.7 million to $28.5 million, for the nine months ended September 30, 2003, compared to $25.8 million for the comparable period of 2002 and remained at 4.9% of net operating revenue. The increase in depreciation and amortization expense was primarily due to depreciation at the two hospitals acquired in 2002.

     Interest expense increased to $19.7 million for the nine months ended September 30, 2003, compared to $16.0 million for the comparable period of 2002, primarily due to the issuance of $200.0 million aggregate principal amount of 7 1/2% Senior Subordinated Notes due 2013, offset by repayments of outstanding borrowings on our senior bank credit facility, repurchases of a portion of our outstanding 4 1/2% Convertible Subordinated Notes due 2005 and entering into a $100.0 million fixed to floating interest rate swap agreement during the third quarter of 2003.

     The write-off of deferred loan costs and the gain resulting from repurchasing a portion of the 4 1/2% Convertible Subordinated Notes at a discount resulted in a net pre-tax loss on extinguishment of debt of $0.5 million during the nine months ended September 30, 2003.

     The provision for income taxes decreased to $19.5 million for the nine months ended September 30, 2003, compared to $21.4 million for the comparable period of 2002, primarily due to the decrease in pre-tax income.

LIQUIDITY AND CAPITAL RESOURCES

     At September 30, 2003, we had working capital of $117.0 million, including cash and cash equivalents of $38.8 million compared to working capital of $105.3 million, including $14.4 million in cash and cash equivalents at December 31, 2002.

     Cash provided by operations was $90.1 million for the nine months ended September 30, 2003, compared to $75.2 million for the same period last year, primarily due to improved cash collections. Our average daily revenues were in accounts receivable an average of 55 days at September 30, 2003, down from an average of 61 days at September 30, 2002. Cash used in investing activities was down significantly to $47.7 million for the nine months ended September 30, 2003, from $207.8 million for the same period last year, primarily due to the purchases of Memorial Hospital of Martinsville and Henry County in May 2002, and Los Alamos Medical Center in June 2002. Net cash used in financing activities totaled $18.0 million for the nine months ended September 30, 2003 compared to $105.4 million of net cash provided by financing activities during the same period last year. Last year’s net cash provided by financing activities primarily reflected borrowings under our revolving credit facility to fund acquisitions.

     During the nine months ended September 30, 2003, we received $194.2 million in net proceeds from the issuance of the 7 1/2% Senior Subordinated Notes due 2013. We used the proceeds, along with existing cash, to repay all amounts outstanding ($114.3 million) on our senior credit facility and to repurchase $74.0 million principal amount of our 4 1/2% Convertible Subordinated Notes due 2005. At September 30, 2003, we had $246.4 million (net of outstanding letters of credit) available for borrowing under our senior credit facility.

19


Table of Contents

     In May 2003, the Board of Directors authorized the repurchase from time to time and subject to market conditions of our 4 1/2% Convertible Subordinated Notes in open market or privately negotiated transactions. Of the $150.0 million principal amount of the 2005 notes originally issued, we had repurchased $74.0 million principal amount through September 30, 2003. Additional repurchases, if any, will be made out of cash provided by operations.

     We intend to acquire additional acute care facilities and are actively seeking out such acquisitions. There can be no assurance that we will not require additional debt or equity financing for any particular acquisition. Also, we continually review our capital needs and financing opportunities and may seek additional equity or debt financing for our acquisition program or other needs.

     Our shelf registration statement on Form S-3, providing for the offer, from time to time, of common stock and debt securities up to an aggregate of $300.0 million, remains effective. Following the issuance of $200.0 million aggregate principal amount of our 7 1/2% Senior Subordinated Notes in May 2003, the shelf registration statement remains available for us to issue up to $100.0 million of additional securities, subject to market conditions and our capital needs.

     Capital expenditures for our owned and leased hospitals may vary from year to year depending on facility improvements and service enhancements undertaken by the hospitals. We expect to make total capital expenditures in 2003 of approximately $60.0 million, exclusive of any acquisitions of businesses or new hospital construction projects. Subsequent to the quarter end, we began construction of a new 41-bed hospital facility in Bluffton, South Carolina, which is expected to be completed in the first quarter of 2005. The total cost of this facility is expected to approximate $32.0 million, with the majority funded during 2004. Planned capital expenditures for 2003 consist principally of capital improvements to owned and leased hospitals. We expect to fund these expenditures through cash provided by operating activities and borrowings under our revolving credit facility.

CRITICAL ACCOUNTING POLICIES AND IMPACT OF RECENTLY ISSUED ACCOUNTING STANDARDS

     A description of the accounting policies we consider critical to our business is contained in our Annual Report on Form 10-K for the year ended December 31, 2002. We have made no changes in those policies since year end.

MARKET RISKS ASSOCIATED WITH FINANCIAL INSTRUMENTS

     Our interest expense is sensitive to changes in the general level of interest rates. To mitigate the impact of fluctuations in interest rates, we generally maintain 50% – 75% of our debt at a fixed rate, either by borrowings on a long-term basis or entering into an interest rate swap.

     During the quarter ended September 30, 2003, we entered into an interest rate swap agreement which effectively converted, for a ten-year period, $100.0 million of the $200.0 million fixed-rate borrowings under our 7 1/2% Senior Subordinated Notes due 2013 to floating-rate borrowings. We secured a LIBOR plus 2.79% floating interest rate over the term of the agreement.

20


Table of Contents

     After giving effect to the interest rate swap agreement, approximately 77% of our debt was at fixed rates as of September 30, 2003.

GENERAL

     The Medicare program accounted for approximately 38.0% and 46.2% of net patient revenue for the nine months ended September 30, 2003 and 2002, respectively. The decrease resulted from the impact of the two acquisitions made in 2002. The Medicaid programs accounted for approximately 11.4% and 12.1% of net patient revenue for the nine months ended September 30, 2003 and 2002, respectively. The majority of payment rates under the Medicare program are now prospective, based upon the diagnosis of a patient. The Medicare payment rate increases historically have been less than actual inflation.

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in our financial statements. Resolution of matters, for example, final settlements with third party payors, may result in changes from those estimates. The timing and amount of such changes in estimates may cause fluctuations in our quarterly or annual operating results.

21


Table of Contents

FORWARD-LOOKING STATEMENTS

     Our disclosure and analysis in this report contain some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements by the fact that they do not relate strictly to historical or current facts. Such statements may include words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe” and other words and terms of similar meaning in connection with any discussion of future operating or financial performance. Any or all of our forward-looking statements in this report may turn out to be wrong. They can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. Many factors mentioned in our discussion in this report will be important in determining future results. Consequently, no forward-looking statement can be guaranteed. Actual future results may vary materially. Factors that may cause our plans, expectations, future financial condition and results to change include, but are not limited to:

    the highly competitive nature of the healthcare business;
 
    the efforts of insurers, healthcare providers and others to contain healthcare costs;
 
    the financial condition of managed care organizations that pay us for healthcare services;
 
    possible changes in the levels and terms of reimbursement for our charges by government programs, including Medicare and Medicaid or other third-party payors;
 
    changes in or failure to comply with federal, state or local laws and regulations affecting the healthcare industry;
 
    the possible enactment of federal or state healthcare reform;
 
    the departure of key members of our management;
 
    claims and legal actions relating to professional liability;
 
    our ability to implement successfully our acquisition and development strategy;
 
    our ability to recruit and retain qualified personnel and physicians;
 
    potential federal or state investigations;
 
    fluctuations in the market value of our common stock or debt securities;
 
    changes in accounting principles generally accepted in the United States or in our critical accounting policies;
 
    changes in demographic, general economic and business conditions, both nationally and in the regions in which we operate;

22


Table of Contents

    changes in the availability, cost and terms of insurance coverage for our hospitals and physicians who practice at our hospitals; and
 
    other risks described in this report.

     Except as required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any additional disclosures and discussions of risks we make in our Form 10-K, 10-Q and 8-K reports and other filings with the Securities and Exchange Commission. These are factors that we think could cause our actual results to differ materially from expected results. Other factors besides those listed here also could affect us adversely. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     During the nine months ended September 30, 2003, there were no material changes in the quantitative and qualitative disclosures about market risks presented in our Annual Report on Form 10-K for the year ended December 31, 2002. Our only derivative instrument relates to an interest rate swap agreement entered into during the three months ended September 30, 2003. See Item 2. “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Market Risks Associated with Financial Instruments.”

ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

     As of the end of the period covered by this report, our management carried out an evaluation, with the participation of our chief executive officer and chief financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based on their evaluation of such controls and procedures, our management concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed by our company in the reports we file under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

     There have been no changes in our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

23


Table of Contents

PART II
OTHER INFORMATION

Item 6. Exhibits and Reports on Form 8-K

(a)   Exhibits

     
Exhibit
Number
  Description of Exhibits

 
3.1   Amended and Restated Certificate of Incorporation of Province Healthcare Company, as filed with the Delaware Secretary of State on June 16, 2000 (a)
3.2   Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Province Healthcare Company, as filed with the Delaware Secretary of State on May 22, 2002 (b)
3.3   Amended and Restated Bylaws of Province Healthcare Company (c)
31.1   Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
31.2   Certification pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (*)
32.1   Certifications pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (**)


         
 
(a)   Incorporated by reference to the exhibits filed with the Registrant’s Quarterly Report filed on Form 10-Q, for the quarterly period ended June 30, 2000, Commission File No. 0-23639.
 
(b)   Incorporated by reference to the exhibits filed with the Registrant’s Registration Statement on Form S-3/A, filed on June 11, 2002, Registration Number 333-86578.
 
(c)   Incorporated by reference to the exhibits filed with the Registrant’s Current Report on Form 8-K, filed on December 12, 2002, Commission File No. 0-23639.

24


Table of Contents

*   Filed herewith
 
**   Furnished herewith

(b)   Reports on Form 8-K
 
During the three months ended September 30, 2003, we furnished the following report on Form 8-K:

  (i)   Form 8-K, furnished on August 4, 2003, with respect to the announcement of our financial results for the second quarter of 2003.

25


Table of Contents

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

         
    PROVINCE HEALTHCARE COMPANY
         
Date: November 10, 2003   By:   /s/ Brenda B. Rector
       
        Brenda B. Rector
Vice President and Controller

26